Shah Capital Management's significant stake and active involvement in Novavax, including board nominations and strategic suggestions, signal potential positive changes in the company's direction. This involvement could lead to improved operational strategies and market positioning, especially in the Covid vaccine segment, which Shah Capital believes Novavax can dominate with the right approach. The public disclosure of these moves and criticisms might also pressure the company's board to act, potentially leading to a positive short-term impact on the stock as investors anticipate these changes.